Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. - Wikidata - wikimedia - TriplyDB

Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.

Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.

http://www.wikidata.org/entity/Q40523209

about

Hepatitis C Therapy in Renal Patients: Who, How, When?Hepatitis C virus infection in nephrology patients Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.Lymphoproliferative disease-related mixed cryoglobulinemia treated with rituximab and prednisolone Hepatitis C virus associated glomerulopathies.Management of the kidney transplant patient with chronic hepatitis C infection Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection Thymic stromal lymphopoietin transgenic mice develop cryoglobulinemia and hepatitis with similarities to human hepatitis C liver disease.Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.Hepatitis C virus and its renal manifestations: a review and update Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects Rituximab-related viral infections in lymphoma patients.Mixed cryoglobulinemia.Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence.Proliferative glomerulonephritis with monoclonal IgG deposits.New insights into HCV-related rheumatologic disorders: A review.Laboratory testing for cryoglobulins.Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies Antiviral therapy for HCV-associated cryoglobulinemic glomerulonephritis: case report and review of the literature.Hepatitis C virus-induced vasculitis: therapeutic options.Extrahepatic manifestations in chronic hepatitis C virus carriers.Hepatitis C infection and chronic renal diseases.The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.Hepatitis C virus (genotype 4)-associated mixed cryoglobulinemia vasculitis: effects of antiviral treatment.Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.Successful combination of Rituximab and plasma exchange in the treatment of cryoglobulinemic vasculitis with skin ulcers: a case report.Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient.Kidneys in chronic liver diseases.Influence of rituximab therapy on hepatitis C virus RNA concentration in kidney-transplant patients.Hepatitis C: the complications of immune dysfunction.Relationship between cryoglobulinemia-associated nephritis and HCV infection.Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab.The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

P2860

Q28077130-2557A369-8E8F-4507-9680-8FFD5C614FA2 Q30486664-9B79046E-BBBC-4F3E-A6A0-321EEAB10835 Q33370836-53D9DD66-6A98-4CF6-8436-8CB52F82D66E Q33628235-76BD0D8F-8DA8-4662-A937-0700DDBB6E47 Q33801278-CDF7AF24-51DB-4276-9836-3DE6D2BEBEAB Q34988932-B95F6CD0-5DF4-44D8-AF6E-2F723489C5A3 Q35731058-128BCFB9-D961-40C3-9086-D9943E38D069 Q35781366-B60DA5F8-5785-4B38-8398-A01E85C6A938 Q36008973-F8008C66-26B2-4BC8-8BD1-82ED2A82F704 Q36496970-20D0D4AF-0AF6-40C5-B898-3C370CB34941 Q36739304-93410695-6FA8-48CA-B6AC-B9212A2E017D Q36871718-436D4681-A98D-4353-91E5-EA26309F76ED Q36942539-D691071B-2FDE-42A1-BCD9-9404FF7F77BB Q37288114-D09B502A-1A49-40AC-8F68-5796340C0B06 Q37330535-FE49F3A1-24C6-4A20-B1E6-5CF5CD48ACA0 Q37610871-7F49367D-2962-4B3A-B737-95D43B9F18FA Q37877205-D09AAAD3-03B6-482F-B125-C1AE073D10B1 Q37940987-932D018B-CC52-4864-8556-7FED2FD2AC17 Q38073147-9195A88C-0D54-458A-B407-6812758CC4DC Q38127143-CEB8DF97-B27A-4C62-83EF-71BE1A05F5E7 Q38388423-A05D000F-D88C-4343-BB76-ABC548D8938F Q38552198-088F58A4-5E9C-464B-82B3-7056B50AE2D3 Q38814211-7BAFAAFA-71EC-44B1-9E4A-2532CD3EC0B9 Q38984942-37E2DCB4-F57C-48DC-981C-93C87025A46C Q40331569-B0D29E5E-CC62-4C61-8B4C-FE6963C43416 Q42268551-EAEB8E7C-5C9F-48D1-A09C-83F6FEDB9171 Q43000192-3E870388-E76D-451D-B472-92F62C5B7B20 Q43209206-78866004-9A3A-403D-A382-D8B2131F05C7 Q45401015-82336FDB-7A24-4526-B95F-9FD807774BC7 Q47580213-D9601C1D-FE1A-44FB-8A9C-8A4D6F9749AB Q50568204-BBF5D7E3-CE95-49BC-A579-777E54CBB360 Q51578806-C96FFB2E-D9B3-4C45-9566-6128F11F7140 Q55228908-07D9C8B0-78C6-4458-A5A2-65FC3569F144 Q58377805-523ABEF4-70A3-4D24-AE47-E5F0C224D732

P2860

Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.

http://www.wikidata.org/entity/Q40523209

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Long-term effects of anti-CD20 ...... bulinaemic glomerulonephritis.

@en

type

label

Long-term effects of anti-CD20 ...... bulinaemic glomerulonephritis.

@en

prefLabel

Long-term effects of anti-CD20 ...... bulinaemic glomerulonephritis.

@en

P1433

Q40523209-E187E98A-2F47-48A8-92C8-DF1CAAD36124

P1476

Q40523209-2820B0B3-6E43-485E-B894-96DE30B61B34

P2093

Q40523209-1703A998-263E-4BED-A218-1A988106E841

Q40523209-1BB671F5-AFC8-4128-AA98-D9DA22E4DD96

Q40523209-208E9E73-904C-4B94-8026-BAAE64ED2AA9

Q40523209-54014F24-33EA-4F46-8A3B-1B205064E869

Q40523209-7C813DAF-42E9-4C13-9977-A0738365BFCD

Q40523209-7CB0011C-5D37-4F84-BF5B-7D81CFCDDF25

Q40523209-CE2D7280-D45A-4273-AA7D-008EA86EB430

Q40523209-EC91B1B5-2A66-4AF7-B288-7EA94D4E3A73

Q40523209-F19CE8B6-1B74-48B9-9511-AF11340DD444

Q40523209-F1B49E62-CF59-4DF4-AD43-1FE583976CE3

P2860

Q40523209-04CFF8EE-252A-4D69-AEE4-9546CFE846CF

Q40523209-12DAD7B4-2571-4FA6-8FA9-8A0D15A41446

Q40523209-295F74F3-FD7B-4BB0-A297-430155636BBA

Q40523209-34ACBDB5-2033-4E31-8CB9-4BEA273D074E

Q40523209-6B3C1B15-4D64-45B7-86BE-1BCA5B3A7266

Q40523209-7CE4041B-42D6-4507-9B8D-8A62CB13798E

Q40523209-818E6527-1FB8-4F83-8DB2-6FAB1FAC5B36

Q40523209-A5D8A0A8-0823-403B-83E3-DB46E186B5C6

Q40523209-B256AC2C-B22E-4FD0-83D7-C1E60E1F2782

Q40523209-B2E773F4-153D-4D2F-AFE4-8ABCC5D7F5F9

P304

Q40523209-9BFDF7E9-CC80-4A4B-982C-3BD664FBCCAC

P31

Q40523209-EDC6377A-9CBB-412C-ADB2-1B914E250C0D

P356

Q40523209-2BE00B06-7130-48AF-833A-A741F216A778

P407

Q40523209-2BF01D78-4476-4F5E-8CB2-F87269032EDA

P433

Q40523209-ECEB0B63-9195-42CF-8DE5-E30EFBC6D0EC

P478

Q40523209-D51D6EFC-5321-4852-981C-F7972C989CA2

P577

Q40523209-51B9F45E-B5AF-4984-925A-0F0DFF27818B

P5875

Q40523209-50C62A94-C34B-4AD2-94FA-230AAD7014E7

P698

Q40523209-DBDB6D28-B53A-4748-8E37-265EA4963A9C

P921

Q40523209-950A7AA7-DB16-4EA6-A318-792FD18D873A

Q40523209-D3401AA9-FEC9-4A1A-824B-1203CC3DB842

P356

P1433

Nephrology Dialysis Transplantation

P1476

Long-term effects of anti-CD20 ...... bulinaemic glomerulonephritis.

@en

P2093

Carla Naretto

http://www.w3.org/2001/XMLSchema#string

Daniela Rossi

http://www.w3.org/2001/XMLSchema#string

Dario Roccatello

http://www.w3.org/2001/XMLSchema#string

Gianna Mazzucco

http://www.w3.org/2001/XMLSchema#string

Luigi Massimino Sena

http://www.w3.org/2001/XMLSchema#string

Mariella Gennaro

http://www.w3.org/2001/XMLSchema#string

Mirella Alpa

http://www.w3.org/2001/XMLSchema#string

Morteza Mansouri

http://www.w3.org/2001/XMLSchema#string

Osvaldo Giachino

http://www.w3.org/2001/XMLSchema#string

Piera Costanzo

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Mixed cryoglobulinemia: new concepts.

Treating human autoimmune disease by depleting B cells

Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.

Efficacy and safety of rituximab in type II mixed cryoglobulinemia.

Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis.

Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment.

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.

Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy.

P304

3054-3061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFH469

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8223442

http://www.w3.org/2001/XMLSchema#string

P698

15494358

http://www.w3.org/2001/XMLSchema#string

P921

glomerulonephritis